DE60306667D1 - Cefdinir salze als zwischenprodukte - Google Patents

Cefdinir salze als zwischenprodukte

Info

Publication number
DE60306667D1
DE60306667D1 DE60306667T DE60306667T DE60306667D1 DE 60306667 D1 DE60306667 D1 DE 60306667D1 DE 60306667 T DE60306667 T DE 60306667T DE 60306667 T DE60306667 T DE 60306667T DE 60306667 D1 DE60306667 D1 DE 60306667D1
Authority
DE
Germany
Prior art keywords
salts
sub
cefdinir
intermediate products
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60306667T
Other languages
English (en)
Inventor
Giovanni Pozzi
Gomez Patricio Martin
Marco Alpegiani
Walter Cabri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olon SpA
Original Assignee
Antibioticos SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antibioticos SpA filed Critical Antibioticos SpA
Application granted granted Critical
Publication of DE60306667D1 publication Critical patent/DE60306667D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60306667T 2002-10-01 2003-09-26 Cefdinir salze als zwischenprodukte Expired - Lifetime DE60306667D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002076A ITMI20022076A1 (it) 2002-10-01 2002-10-01 Sali di intermedi del cefdinir.
PCT/EP2003/010718 WO2004035800A2 (en) 2002-10-01 2003-09-26 Intermediate cefdinir salts

Publications (1)

Publication Number Publication Date
DE60306667D1 true DE60306667D1 (de) 2006-08-17

Family

ID=32104767

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60306667T Expired - Lifetime DE60306667D1 (de) 2002-10-01 2003-09-26 Cefdinir salze als zwischenprodukte

Country Status (10)

Country Link
US (1) US7405294B2 (de)
EP (1) EP1546155B1 (de)
JP (1) JP2006501305A (de)
AT (1) ATE332304T1 (de)
AU (1) AU2003293585A1 (de)
CA (1) CA2500791A1 (de)
DE (1) DE60306667D1 (de)
ES (1) ES2268467T3 (de)
IT (1) ITMI20022076A1 (de)
WO (1) WO2004035800A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020913A0 (it) * 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
KR20050087776A (ko) * 2002-08-13 2005-08-31 산도즈 아게 세프디니르 중간체
WO2004046154A1 (en) * 2002-11-15 2004-06-03 Orchid Chemicals & Pharmaceuticals Ltd Novel amorphous hydrate of a cephalosporin antibiotic
CN100357294C (zh) * 2003-03-24 2007-12-26 桑多斯股份公司 7－[2－(2－氨基噻唑－4－基)－2－羟基亚氨基乙酰胺－3－乙烯基－3－头孢烯－4－羧酸(顺式异构体)的新型晶体和其制备方法
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
EP1765833A2 (de) * 2004-07-05 2007-03-28 Orchid Chemicals and Pharmaceuticals Limited Neue salze bei der herstellung von cephalosporinantibiotika
ITMI20042231A1 (it) * 2004-11-19 2005-02-19 Antibioticos Spa Cefdinir sale d'ammonio in forma cristallina
MX2007006018A (es) 2004-11-30 2007-06-07 Astellas Pharma Inc Suspension farmaceutica oral novedosa de cristal de cefdinir.
WO2007053723A2 (en) * 2005-10-31 2007-05-10 Teva Pharmaceutical Industries Ltd. Process for the preparation of cefdinir
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
ITMI20071628A1 (it) * 2007-08-06 2007-11-05 Acs Dobfar Spa Sintesi di 3-alchenilcefalosporine e nuovi intermedi utili ad esse correlati
US9839395B2 (en) * 2007-12-17 2017-12-12 Dexcom, Inc. Systems and methods for processing sensor data
KR101058135B1 (ko) * 2008-04-04 2011-08-24 대웅바이오 주식회사 세프디니르 합성에 유용한 중간체 및 이를 이용하여세프디니르를 제조하는 방법
CN101481383B (zh) * 2008-12-31 2012-01-11 杭州奥默医药技术有限公司 头孢地尼酸式复盐化合物及制备方法
TR200909784A1 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Yeni sefdinir tuzları
CN102020664B (zh) * 2010-11-30 2012-12-12 浙江工业大学 一种头孢地尼的合成方法
CN102617506B (zh) * 2011-01-31 2015-04-01 石药集团中奇制药技术（石家庄）有限公司 一种头孢地尼及其中间体的制备方法
CN102617601A (zh) * 2011-01-31 2012-08-01 石药集团中奇制药技术（石家庄）有限公司 一种头孢地尼的制备方法
CN115612473B (zh) * 2022-10-11 2023-07-04 中国科学院兰州化学物理研究所 一种耐高温酸化缓蚀剂及其制备方法和应用、缓蚀酸化压裂液

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA806977B (en) * 1979-11-19 1981-10-28 Fujisawa Pharmaceutical Co 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US5114958A (en) * 1991-05-09 1992-05-19 Warner-Lambert Company 1,2,4-oxadiazole and 1,2,4-thiadiazole derivatives of fenamates as antiinflammatory agents
ATE218572T1 (de) * 1995-12-27 2002-06-15 Hanmi Pharmaceutical Co Ltd Verfahren zur herstellung von cefdinir
TW538045B (en) * 1997-01-16 2003-06-21 Biochemie Gmbh Process for purifying cefixime
AT405283B (de) * 1997-04-04 1999-06-25 Biochemie Gmbh Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung
US6319955B1 (en) * 1998-01-06 2001-11-20 The General Hospital Corporation Use of MEK1 inhibitors as protective agents against damage due to ischemia
US6153645A (en) * 1998-09-18 2000-11-28 Cubist Pharmaceuticals, Inc. Heterocycles as antimicrobial agents
US6346583B1 (en) * 1999-08-25 2002-02-12 General Electric Company Polar solvent compatible polyethersiloxane elastomers
KR20020063227A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 신규한 리포펩티드
JP4544692B2 (ja) * 2000-04-13 2010-09-15 大塚化学株式会社 ３−ビニル−セフェム化合物の製造方法
KR100451672B1 (ko) 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
CA2379375A1 (en) * 2002-03-28 2003-09-28 Apotex Inc. Sulfonamide derivatives of 3-substituted imidazol[1,2-d]-1,2,4-thiadiazoles and 3-substituted-[1,2,4] thiadiazolo[4,5-a] benzimidazole as inhibitors of fibrin cross-linking and transglutaminases
US6960654B2 (en) * 2002-06-11 2005-11-01 The Board Of Trustees Of The University Of Illinois Method of forming glycosidic bonds from thioglycosides using an N,N-dialkylsulfinamide
WO2004046154A1 (en) * 2002-11-15 2004-06-03 Orchid Chemicals & Pharmaceuticals Ltd Novel amorphous hydrate of a cephalosporin antibiotic
ITMI20022724A1 (it) * 2002-12-20 2004-06-21 Antibioticos Spa Sali cristallini del cefdinir.
US20050119244A1 (en) * 2003-12-02 2005-06-02 Acs Dobfar S.P.A. Process for preparing cephalosporins with salified intermediate
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
EP1765833A2 (de) * 2004-07-05 2007-03-28 Orchid Chemicals and Pharmaceuticals Limited Neue salze bei der herstellung von cephalosporinantibiotika
ITMI20042231A1 (it) * 2004-11-19 2005-02-19 Antibioticos Spa Cefdinir sale d'ammonio in forma cristallina

Also Published As

Publication number Publication date
ITMI20022076A1 (it) 2004-04-02
WO2004035800A2 (en) 2004-04-29
US7405294B2 (en) 2008-07-29
CA2500791A1 (en) 2004-04-29
EP1546155B1 (de) 2006-07-05
WO2004035800A3 (en) 2004-08-26
ES2268467T3 (es) 2007-03-16
EP1546155A2 (de) 2005-06-29
JP2006501305A (ja) 2006-01-12
AU2003293585A1 (en) 2004-05-04
US20060111566A1 (en) 2006-05-25
ATE332304T1 (de) 2006-07-15
AU2003293585A8 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
DE60306667D1 (de) Cefdinir salze als zwischenprodukte
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
NO20062656L (no) Fremgangsmate for fremstilling av statiner
DE69709938D1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
CY1112711T1 (el) ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΠΑΡΑΓΩΓΩΝ ΚΥΚΛΟΠΕΝΤΑ[g]ΚΙΝΑΖΟΛΙΝΗΣ
ATE342887T1 (de) Verfahren zur herstellung von aryloctanoyl-amiden
EA200300804A1 (ru) Усовершенствованный способ получения карбапенема
ATE370131T1 (de) Verfahren zur herstellung von 5-(1,3-oxazol-2- yl)benzoesäurederivaten
ATE231160T1 (de) Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
ATE496907T1 (de) Verfahren zur herstellung von cilostazol
WO2005037780A3 (de) Amidomethyl-substituierte 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromen-6-yl-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EA200000924A3 (ru) СПОСОБ ПОЛУЧЕНИЯ ПИРАЗОЛО[4,3-d]ПИРИМИДИН-7-ОН-3-ПИРИДИЛСУЛЬФОНИЛЬНЫХ СОЕДИНЕНИЙ И ИХ ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
EE05136B1 (et) Asendatud imidasopridiinhendite valmistamise meetod
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
ATE270287T1 (de) 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme
ATE244706T1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
WO2004096828A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes
ATE330612T1 (de) Verfahren zur herstellung von benazeprilhydrochloride
EA200500224A1 (ru) МИКРОБИОЛОГИЧЕСКИЕ СПОСОБЫ ПОЛУЧЕНИЯ 7α-ЗАМЕЩЁННЫХ 11α-ГИДРОКСИСТЕРОИДОВ
NO20030605D0 (no) Fremgangsmåte for fremstilling av imidazo-(1,2-C)(2,3)- benzodiazepiner, samt mellomprodukter ved fremstillingen derav
WO2004096829A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes-17-halogenes
WO2001018231A3 (de) VERFAHREN ZUR HERSTELLUNG VON (R)- ODER (S)-HYDROXY-η-BUTYROLACTON

Legal Events

Date Code Title Description
8332 No legal effect for de